OL
OWL Lifesciences develops neurotherapeutics by leveraging a proprietary platform centered on automated, in vitro human CNS models. This technology generates clinically-relevant longitudinal multimodal data, which is then analyzed using Artificial Intelligence. The company's approach aims to accelerate the discovery and development of advanced therapeutic modalities and in vivo delivery strategies for neurological conditions.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- OWL Lifesciences develops neurotherapeutics by leveraging a proprietary platform centered on automated, in vitro human Central Nervous System (CNS) models. This technology generates clinically-relevant longitudinal multimodal data, which is then integrated with Artificial Intelligence. The company provides a solution for discovering and developing advanced therapeutic modalities and in vivo delivery strategies for neurological conditions.